(15:11 GMT) ProQR Therapeutics Price Target Raised to $6.00/Share From $5.00 by Evercore ISI Group
Dow Jones Newswires
ProQR Therapeutics Is Maintained at Outperform by Evercore ISI Group
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:PRQR
- Language
- English